Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.

Małgorzata Bilińska, Irena Frydecka, Ryszard Podemski, Renata Teodorowska, Ewa Gruszka

Med Sci Monit 2001; 7(2): CR251-255 :: ID: 421153

Abstract

BACKGROUND: During the relapse of multiple sclerosis, the activation ofT cells, autoreactive to myelin antigens in blood, enhanced and maintained as a result of anomalous mechanismsof their earlier elimination, leads on para- and autocrine basis to the activation of antigen- non-specificcells of immune system. In consequence, activated cells secrete a range of proinflammatory cytokinesand display activation antigen expression on their surface, which results in blood-brain barrier damage.The differentiation of lymphocytes into effector cells in blood during MS relapse is to increase thenumber of cells supporting inflammatory reactions and simultaneously to reduce the number of cells whichplay a role of suppressors. Fas antigen is present among activation antigens found on T cells. Once thisantigen has been combined with the ligand, it transmits apoptic signal to the cell. The presence of Fasantigen on activated peripheral blood T cells may enable us to estimate their activation and it may alsoindicate a potential to eliminate those cells from blood. The aim of the study was to provide a quantitativeassessment of the subpopulations of CD3, CD4 and CD8 lymphocytes in peripheral blood and to investigateFas antigen expression on these subsets in patients with relapsing-remitting multiple sclerosis, in relationto clinical activation of the disease.
MATERIAL AND METHODS: Thirty-five patients participated in thestudy, including 14 patients finding themselves in clinical relapse of the disease and 21 patients inthe state of remission. Additionally, 21 healthy subjects were included. Quantitative assessment of individualsubpopulations and Fas co-expression was carried out with the use of monoclonal antibodies anti CD3,CD4 and CD8 as well as anti CD95 antibodies, and flow cytometer Pas/Dako Galaxy.
RESULTS: The differencesin the percentage of particular lymphocytes between 3 groups proved insignificant. Patients in the relapseof the disease showed significantly greater Fas expression on subpopulations CD3 and CD4 when comparedto the results obtained from remission patients and control subjects. This difference was not observedfor Fas expression on subset CD8.
CONCLUSIONS: The investigation of Fas receptor expression may be usefulin order to monitor clinical course of the disease, which is characterised by the periods of exacerbationand remission.

Keywords: Multiple Sclerosis, Fas antigen, T cells

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750